The FDA has cleared the new version for across most of the solid tumour indications already granted for Keytruda, which is ...
Though Keytruda QLEX will be more patient-centric, analysts are sceptical of the drug’s capacity to stave off generic ...
A dedicated energy team is helping the global healthcare company to achieve net zero by 2045 Read more at The Business Times.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback